:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/41286409/32f1479b78fa4566e353f4ad277dd8cb_wm.png)
Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapy.
Summary: Imagine if we could turn a cancer's shield into a weapon against it. Tumors often create a special protective environment that stops our immune cells—like CAR-T cells—from fighting back. Scientists have now used computers to design a new, artificial receptor called T-SenSER. This receptor acts like a smart switch on the outside of the immune cell. When it senses the tumor's protective signals, it flips them into a massive boost of energy for the immune cells. In laboratory tests on lung and bone marrow cancers, combining standard CAR-T cells with this new T-SenSER switch made the immune cells much stronger at destroying the cancer. This exciting discovery could lead to much better, custom-built treatments for cancer patients in the future.